Ovison 1 mg/g creme

Ovison is a topical corticosteroid cream containing mometasone furoate, primarily used to treat inflammatory skin conditions such as eczema and psoriasis. The brand originated in Italy, where it was developed by Abiogen Pharma S.p.A., a pharmaceutical company based in Pisa. In 2025, the ultimate owner of the Ovison brand is MDM Holding S.p.A., an Italian company that oversees the operations of Abiogen Pharma S.p.A. and other pharmaceutical entities. The manufacturing of Ovison is primarily based in Italy, but it is also produced in other locations to meet global demand. The brand is not associated with any local subsidiaries in Denmark, as it is distributed by Galenica AB in the Danish market.